Search Results
271 Results for 'Therapeutics & Vaccines'
PAGE 8 OF 11
Technology
Circular Strained Zymogen Compositions And Methods Of Use
Disclosed herein are circular zymogens of RNase 1 that have a proteolytic cleavage site and are activated by a specific protease. These circular zymogens are useful for treatment of disorders that are...
Learn More
Learn More
Ronald Raines, Ian Windsor | P190190US02
Technology
Modified Clostridial Neurotoxins As Vaccines And Conjugate Vaccine Platforms
Provided herein are engineered non-catalytic, non-toxic tetanus toxin variants and methods of using such engineered tetanus toxin variants as low dose, protective vaccines that are non-toxic and more ...
Learn More
Learn More
Eric Johnson, Sabine Pellett, William Tepp, Joseph Barbieri, Amanda Przedpelski | P190179US02
Technology
Improved Influenza Virus Replication For Vaccine Development
An isolated recombinant influenza virus is provided having PA, PB1, PB2, NP, NS, M, NA and HA viral segments, wherein the PB1 viral segment encodes a PB1 with a residue other than isoleucine at positi...
Learn More
Learn More
Yoshihiro Kawaoka, Gabriele Neumann, Jihui Ping | P190171US02
Technology
HLF-VC1 Master Cell Bank for Vaccine Development
FDA-qualified cell lines must be used for virus production for human vaccines. There are relatively few of these lines available and several (WI-38, MRC-5) used for virus production are becoming senes...
Learn More
Learn More
James Gern | P160170US01
Technology
A Novel Series of Antimicrobials Target Bacteria Membranes to Overcome Antibiotic Resistance
Drug resistant pathogens continue to emerge as the rate of the development of new antimicrobials to combat them continues to decline. Alarmingly, slow-growing bacteria associated with dangerous and pr...
Learn More
Learn More
Douglas Weibel, Ye Jin Eun, Marie Foss, Katherine Hurley | P120204US02
Technology
Oligolactic Acid-Paclitaxel and Oligolactic Acid-Docetaxel Prodrugs for Injection
PTX, DTX, rapamycin and selumetinib are potent chemotherapeutic agents useful in the treatment of a variety of cancers. Due to their limited water solubility, PTX and DTX are commonly formulated for p...
Learn More
Learn More
Glen Kwon, Yu Tong (Tony) Tam | P160169US03
Technology
Compounds and Methods for Modulating Frataxin Expression in Friedreich’s Ataxia
Friedreich’s Ataxia (FRDA) is a neurodegenerative disorder without treatments to halt or reverse disease progression, affecting roughly 9,000 Americans. FRDA is caused by triplet expansion in the fi...
Learn More
Learn More
Aseem Ansari, Graham Erwin, Matthew Grieshop | P160232US07
Technology
Gene Correction of Pompe Disease and Other Autosomal Recessive Disorders via CRISPR and other RNA-Guided Nucleases
Pompe disease is a rare autosomal recessive genetic disease (mutations from both parent carriers have to be inherited by the offspring to see symptoms) that typically affects children during developme...
Learn More
Learn More
Krishanu Saha, Jared Carlson-Stevermer, Lucille Kohlenberg | P190021US02
Technology
Bacterial Membrane Nanoparticles as an Immunotherapy System for Cancer Treatment
Cancer immunotherapy – a therapy that stimulates and employs the body’s own immune system – is one of the most promising new approaches for treating cancer. Despite its tremendous potential, it ...
Learn More
Learn More
Shaoqin Gong, Zachary Morris, Mingzhou Ye, Ravi Patel, Paul Sondel | P180331US02
Technology
Bioengineered Vocal Fold Mucosa for Voice Restoration
Voice impairment (dysphonia) affects an estimated 20 million people in the U.S., resulting in reduced quality of life and direct health care costs exceeding $11 billion per year. Between 60 and 80 per...
Learn More
Learn More
Nathan Welham, Changying Ling | P140307US02
Technology
Inhibiting Quorum Sensing in Staphylococcus Epidermidis, a Health Care Pathogen
Staphylococcus epidermidis is an important Gram-negative bacterial pathogen in hospital-acquired infections, and the most common cause of infections on indwelling medical devices. The costs related to...
Learn More
Learn More
Helen Blackwell, Tian Yang | P150348US02
Technology
Phospholipid Ether Analogs for Treating and Imaging Pediatric Solid Tumors
Currently there is only one well-studied and established tumor-targeting radioactive agent in pediatric oncology (131I-MIBG), which only targets neuroblastoma and other rare neuroendocrine tumors. It ...
Learn More
Learn More
Mario Otto, Bryan Bednarz, Jamey Weichert, Dana Baiu | P160325US02
Technology
Engineered Probiotics as Systemic Therapeutic Delivery Platform
Polypeptides, such as enzymes, antibodies, hormones and cytokines, are useful therapeutic agents. However, routes for systemically introducing such polypeptides to a subject are limited. Oral administ...
Learn More
Learn More
Jan Peter Van Pijkeren, Alan Attie, Mark Keller, Jeehwan Oh | P160109US02
Technology
Novel Small Molecule SIRT6 Activators/Inhibitors
The epigenetic modifier SIRT6 is of the sirtuin class of proteins. In transgenic mice, increased SIRT6 expression lowers LDL and triglyceride levels, improves glucose tolerance and increases mitochond...
Learn More
Learn More
John Denu, Weiping Tang | P160306US01
Technology
Synstatin “SSTNI/V” Disrupts Cancer Growth
Leading UW–Madison oncologists previously showed that the matrix receptor syndecan-1 (Sdc1/CD138) – a matrix receptor highly expressed in multiple myeloma – captures and activates multiple cell ...
Learn More
Learn More
Alan Rapraeger, DeannaLee Beauvais, Oisun Jung | P160224US02
Technology
Synthesizing Natural Products to Treat High Blood Cholesterol
Indole is one of the most abundant heterocycles in pharmaceuticals and bioactive natural products, such as indometacin, a non-steroid anti-inflammatory drug, and vincristine, a natural product used to...
Learn More
Learn More
Weiping Tang, Dongxu Shu, Gabrielle Winston-McPherson, Xiaoxun Li | P150023US03
Technology
Compounds to Treat Hyperlipidemia and Fatty Liver Disease
Hyperlipidemia is a condition strongly associated with obesity and is an independent risk factor for the development of coronary heart disease. To help combat hyperlipidemia, the pharmaceutical indust...
Learn More
Learn More
Mark Keller, Alan Attie, Sheldon Engelhorn, Nikolai Sepetov, Sergei Romanov, David Bernlohr | P110006US01
Technology
Enzyme Aids Intranasal Drug Delivery
Currently, delivering drugs directly into the brain requires invasive surgery. This is because a tight cellular layer called the blood-brain barrier (BBB) not only prevents harmful substances from ent...
Learn More
Learn More
Robert Thorne, Jeffrey Lochhead | P120322US02
Technology
New Compounds for Treating High Blood Cholesterol and More
Indole is one of the most abundant heterocycles in pharmaceuticals and bioactive natural products, such as indometacin, a non-steroid anti-inflammatory drug, and vincristine, a natural product used to...
Learn More
Learn More
Weiping Tang, Xiaoxun Li | P150140US02
Technology
Methods and Compositions for Treating Prostate Cancer Using DNA Vaccines
Prostate cancer is a significant health risk for men over the age of 50 and currently is a pervasive health threat with as many as 200,000 new cases diagnosed each year in the US alone. At present, t...
Learn More
Learn More
Douglas McNeel, Brian Olson | P05235US
Technology
Combinatorial Androgen Deprivation With An Androgen Receptor Vaccine
The androgen receptor (AR) is a steroid hormone receptor that plays a crucial role in the development of normal prostate tissue, as well as in the progression of prostate cancer. Patients with metasta...
Learn More
Learn More
Douglas McNeel, Brian Olson | P160108US02
Technology
Use of Salate Derivatives to Treat Multiple Sclerosis
Multiple sclerosis (MS) is a chronic inflammatory autoimmune disease affecting 2.5 million people worldwide. The disease is difficult to manage and there is no cure. The underlying mechanism of MS pro...
Learn More
Learn More
Hector DeLuca, Lori Plum, Steven Marling, Yanping Wang | P160384US02
Technology
Compounds And Methods For Modulating Frataxin Expression
Friedreich’s ataxia (also referred to as FA or FRDA) is a rare but fatal autosomal recessive neurodegenerative disease. With an estimated incidence of 1 in every 40,000 people, it causes progressive...
Learn More
Learn More
Aseem Ansari, Graham Erwin, Matthew Grieshop | P160232US05
Technology
Improved Influenza B Virus Replication for Vaccine Development
The epidemiology of influenza Type B viruses differs from Type A; influenza B viruses primarily circulate in humans and do not cause pandemics. However, in some seasons the impact of influenza B infec...
Learn More
Learn More
Yoshihiro Kawaoka, Gabriele Neumann, Jihui Ping | P160181US02
Technology
SIgA Protein as Heath Supplement for Animals, Humans
Secretory immunoglobulin A (sIgA) plays a critical role in immunity. The protein is found in breast milk and secreted in the gastrointestinal system during development and adulthood. Research suggests...
Learn More
Learn More
Mark Cook, Jordan Sand | P120329US01